Characterization of oleanolic acid derivative for colon cancer targeting with positron emission tomography

Area of Science:

• Pharmacology
• Oncology
• Biochemistry

Background:

• Oleanolic acid (OA), a pentacyclic triterpenoid from plants, exhibits anticancer properties by inhibiting tumor proliferation and inducing apoptosis.
• Existing research highlights the potential of triterpenoids in cancer therapy, necessitating further investigation into novel derivatives.

Purpose of the Study:

• To synthesize and evaluate an oleanolic acid derivative for its efficacy against human colon cancer.
• To assess the potential of radioisotope-labeled OA as an imaging tool for noninvasive tumor monitoring.

Main Methods:

• Synthesis of an oleanolic acid derivative and evaluation of its antiproliferative and pro-apoptotic effects on HT-29 colon cancer cells.
• Analysis of key gene expression changes (cyclin D1, Cox-2, Bcl-2, Bcl-xL, Bax) and protein levels (NF-κB, IκB, PARP-1) following treatment.
• Preparation of radioisotope-labeled OA (68Ga-NOTA-OA) and assessment of tumor uptake using biodistribution and positron emission tomography (PET) imaging in a human colon cancer xenograft model.

Main Results:

• The OA derivative demonstrated a concentration-dependent decrease in HT-29 cell survival and increased apoptosis.
• Treatment led to downregulation of pro-survival genes (cyclin D1, Cox-2, Bcl-2, Bcl-xL) and upregulation of pro-apoptotic Bax.
• Significant reduction in NF-κB p65 and IκB expression, alongside increased cleaved PARP-1, indicated apoptosis induction. 68Ga-NOTA-OA exhibited high tumor uptake in vivo.

Conclusions:

• The synthesized OA derivative possesses significant anticancer properties, including antiproliferative and pro-apoptotic effects against human colon cancer cells.
• The compound shows promise as a dual-acting agent for both colon cancer therapy and targeted tumor imaging.